Urine Neutrophil Gelatinase-associated Lipocalin and Urine Output As Predictors of the Successful Discontinuation of Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2020 Aug 30

PMID 32859163

Citations 6

Authors

Josefine Thomsen

Ulrik Sprogoe

Palle Toft

Affiliations

Soon will be listed here.

Abstract

Background: Continuous renal replacement therapy (CCRT) is a frequently used modality for the support of intensive care patients with acute kidney injury (AKI). Nevertheless, there are no objective criteria for the discontinuation of CRRT. The purpose of this study was to investigate whether urine neutrophil gelatinase-associated lipocalin (uNGAL) alone or in combination with urine output could be used as a diagnostic test for renal function recovery in ICU patients on CRRT.

Methods: This was a single-centre prospective observational study including patients with acute kidney failure needing CRRT. Sixty-nine patients were enrolled, and 54 completed the study. Of the 54 patients, 22 recovered renal function (REC), defined as dialysis independency at 72 h from discontinuation, while 32 patients did not (NREC). Urine NGAL was measured at 0, 6, 12, and 24 h after CRRT discontinuation. The cumulated urine output was measured for 24 h prior to discontinuation and at 6, 12, and 24 h after discontinuation. Missing uNGAL values were calculated by interpolation. The Youden's index was used to calculate cut-off values in order to define uNGAL and urine output single variable and 2-variable diagnostic tests with the optimum prediction of successful CRRT discontinuation.

Results: Baseline characteristics at CRRT initiation were similar between groups. Compared to the NREC group, the REC group had significantly higher urine output (p < 0.0001) and lower uNGAL (p < 0.001) at all time points, except for uNGAL at 24 h (p < 0.24). The best uNGAL predictor for successful CRRT discontinuation was uNGAL at 6 h after discontinuation (predictive value 80%). The best single predictor was cumulated urine output 24 h before discontinuation (predictive value 85%). The combinations of uNGAL at 6 h (cut-off 1650 μg/L) with cumulated urine output 24 h prior to discontinuation (cut-off 210 ml) proved to be the superior tests (using either "or" or "and"), with predictive values of 93% (successful CRRT discontinuation) and 92% (dialysis dependency).

Conclusions: With a predictive value of 93%, the combination of uNGAL at 6 h after and the cumulated urine output 24 h prior to CRRT cessation proved to be the best diagnostic test for successful CRRT discontinuation in ICU patients.

Clinical Trial Registration: N/A.

Citing Articles

Weaning from Kidney Replacement Therapy in the Critically Ill Patient with Acute Kidney Injury.

Klouche K, Brunot V, Larcher R, Lautrette A J Clin Med. 2024; 13(2).

PMID: 38276085 PMC: 10816626. DOI: 10.3390/jcm13020579.

A clinical model to predict successful renal replacement therapy (RRT) discontinuation in patients with Acute Kidney Injury (AKI).

Valle E, Smolentzov I, Gorzoni J, Salgado I, Mainardes L, Gomes V Clinics (Sao Paulo). 2023; 78:100280.

PMID: 37690142 PMC: 10497780. DOI: 10.1016/j.clinsp.2023.100280.

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study.

Komaru Y, Oguchi M, Sadahiro T, Nakada T, Hattori N, Moriguchi T Ann Intensive Care. 2023; 13(1):42.

PMID: 37184598 PMC: 10185728. DOI: 10.1186/s13613-023-01137-6.

Analysis of urinary C-C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study.

Qian B, Jia H, Weng Y, Li X, Chen C, Guo F J Intensive Care. 2023; 11(1):11.

PMID: 36941674 PMC: 10026399. DOI: 10.1186/s40560-023-00659-2.

ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.

Mishra R, Sodhi K, Prakash K, Tyagi N, Chanchalani G, Annigeri R Indian J Crit Care Med. 2023; 26(Suppl 2):S13-S42.

PMID: 36896356 PMC: 9989875. DOI: 10.5005/jp-journals-10071-24109.

References

Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A . Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 54(6):1012-24. DOI: 10.1053/j.ajkd.2009.07.020. View

Zhang A, Cai Y, Wang P, Qu J, Luo Z, Chen X . Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care. 2016; 20:41. PMC: 4754917. DOI: 10.1186/s13054-016-1212-x. View

Romero-Gonzalez G, Lorenzin A, Neri M, Ferrari F, Molano-Trivino A, Brendolan A . Discontinuation of Continuous Renal Replacement Therapy and Dialysis Dependence. Contrib Nephrol. 2018; 194:118-125. DOI: 10.1159/000485609. View

Yang T, Sun S, Zhao Y, Liu Q, Han M, Lin L . Biomarkers upon discontinuation of renal replacement therapy predict 60-day survival and renal recovery in critically ill patients with acute kidney injury. Hemodial Int. 2017; 22(1):56-65. DOI: 10.1111/hdi.12532. View

Frohlich S, Donnelly A, Solymos O, Conlon N . Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy. J Crit Care. 2012; 27(6):744.e1-5. DOI: 10.1016/j.jcrc.2012.08.012. View

Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I . Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009; 37(9):2576-82. DOI: 10.1097/CCM.0b013e3181a38241. View

Mishra J, Dent C, Tarabishi R, Mitsnefes M, Ma Q, Kelly C . Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365(9466):1231-8. DOI: 10.1016/S0140-6736(05)74811-X. View

de Geus H, Haase M, Jacob L . The cardiac surgery-associated neutrophil gelatinase-associated lipocalin score for postoperative acute kidney injury: Does subclinical acute kidney injury matter?. J Thorac Cardiovasc Surg. 2017; 154(3):939-940. DOI: 10.1016/j.jtcvs.2017.05.005. View

Srisawat N, Wen X, Lee M, Kong L, Elder M, Carter M . Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol. 2011; 6(8):1815-23. PMC: 3156420. DOI: 10.2215/CJN.11261210. View

10.

Wu V, Ko W, Chang H, Chen Y, Lin Y, Shiao C . Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med. 2007; 34(1):101-8. DOI: 10.1007/s00134-007-0813-x. View

11.

Hoste E, Bagshaw S, Bellomo R, Cely C, Colman R, Cruz D . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015; 41(8):1411-23. DOI: 10.1007/s00134-015-3934-7. View

12.

Bennett M, Dent C, Ma Q, Dastrala S, Grenier F, Workman R . Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008; 3(3):665-73. PMC: 2386703. DOI: 10.2215/CJN.04010907. View

13.

Katayama S, Uchino S, Uji M, Ohnuma T, Namba Y, Kawarazaki H . Factors predicting successful discontinuation of continuous renal replacement therapy. Anaesth Intensive Care. 2016; 44(4):453-7. DOI: 10.1177/0310057X1604400401. View

14.

Zhou F, Luo Q, Wang L, Han L . Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg. 2015; 49(3):746-55. DOI: 10.1093/ejcts/ezv199. View

15.

Stads S, Kant K, de Jong M, de Ruijter W, Cobbaert C, Betjes M . Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study. BMC Nephrol. 2019; 20(1):129. PMC: 6466643. DOI: 10.1186/s12882-019-1327-9. View

16.

Heise D, Gries D, Moerer O, Bleckmann A, Quintel M . Predicting restoration of kidney function during CRRT-free intervals. J Cardiothorac Surg. 2012; 7:6. PMC: 3275482. DOI: 10.1186/1749-8090-7-6. View